The iShares Biotechnology ETF is up over 32% in six months on rate cut expectations and potential sector rotation. The State Street SPDR S&P Biotech ETF has surged 45% in six months but remains 27% ...

Although the equities market often embodies chaos and capricious non-linearity, few sectors witness as much kinetic wildness like biotechnology. At its core, biotech represents an innovative push ...

IBB and XBI are similar in many ways, but their relative past performance does not tell the story. IBB is more concentrated, and that is ultimately why I prefer it to XBI. Both ETFs target a similar ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

Investors and retirement savers who want to own broad swaths of the stock and bond markets often face a choice: Do they want to buy time-honored mutual funds, or upstart exchange-traded funds? If ...

Franklin Templeton today announced it will liquidate and dissolve Putnam BioRevolution™ ETF (SYNB). The liquidation is anticipated to occur on or about November 21, 2025, although the Fund may make ...

Seers Technology, D&D Pharmatech, OliX, ABL Bio. Among the top 10 stocks with the highest stock price increases this year, four were bio and healthcare-related stocks. Seers Technology, an AI medical ...